FIELD: medicine.
SUBSTANCE: patient's blood plasma is examined for a fractalkine level by ELISA. That is followed by calculating the aggravated bronchial asthma duration (ng/ml) by formula derived by multiple regression analysis: T=B1+B2×Fractalkine, wherein T is the aggravated bronchial asthma duration (days), B1 is a standartised Beta coefficient equal to 8.022120, B2 is a standartised Beta coefficient equal to 6.625970, Fractalkine is the fractalkine level.
EFFECT: use of the method enables providing high-accuracy prediction of the aggravated bronchial asthma duration.
2 tbl, 3 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATION OF MICROVASCULAR ENDOTHELIUM STATUS IN PATIENTS WITH BRONCHIAL ASTHMA | 2010 |
|
RU2436091C1 |
| METHOD OF DIAGNOSING ENDOTHELIAL DYSFUNCTION BY TYPES OF MICROVASCULAR ENDOTHELIUM RESPONSE | 2010 |
|
RU2449282C1 |
| METHOD OF ACHIEVING CONTROL OVER BRONCHIAL ASTHMA | 2013 |
|
RU2571894C2 |
| METHOD FOR PREDICTION OF INCIDENCE OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2023 |
|
RU2822081C1 |
| METHOD OF OPTIMISATION TREATMENT OF BRONCHIAL ASTHMA | 2009 |
|
RU2403073C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA | 2012 |
|
RU2497117C2 |
| METHOD OF PROGNOSIS OF EFFICIENCY OF BRONCHIAL ASTHMA BASIC THERAPY IN CHILDREN | 2007 |
|
RU2356054C1 |
| METHOD FOR TREATING THE CASES OF BRONCHIAL ASTHMA | 1994 |
|
RU2114653C1 |
| METHOD FOR PREDICTING EXACERBATIONS OF BRONCHIAL ASTHMA FOR THE NEAR FIRST YEAR IN PATIENTS WITH CONCOMINANT OBESITY | 2018 |
|
RU2655829C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF TYPES OF INFLAMMATION OF RESPIRATORY TRACT IN PATIENTS WITH BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2017 |
|
RU2678577C1 |
